PFIZER

Pfizer shows signs of stabilizing after a strong multi-year correction, currently consolidating around $24–$27.

Technical structure suggests the completion of a five-wave downtrend, with the potential start of a new corrective phase (Wave B–C).

Momentum indicators (RSI & MACD) show early bullish divergence, hinting at the beginning of a mid-term recovery.

Key resistance zones lie at $31, $54, and $60, while the $21–$24 range acts as a strong support base.

Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical company headquartered in New York City, known for developing and manufacturing innovative medicines and vaccines.

The company operates across key therapeutic areas, including immunology, oncology, cardiology, and infectious diseases.

Pfizer is also a major contributor to global healthcare innovation through its research-driven approach and collaborations aimed at improving public health worldwide.

Monthly

Weekly